Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jan 20;17(1):134. doi: 10.3390/ijms17010134

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 by the authors; licensee MDPI, Basel, Switzerland.

This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Both VLDLs caused LV dilation but only MetS-VLDL caused left atrial dilation. (A) Echocardiography of murine heart. Left atrium (LA) and left ventricle (LV) were identified in B-mode; (B) M-mode images for measurements of diameters of aortic root (AO), LA and LV. LA was significantly enlarged in the MetS-VLDL injection group (msVLDL) (n = 6) but not in the normal-VLDL injection group (nVLDL) (n = 7) or the control group (n = 5); (C) Significant LA enlargement developed as early as 4–6 weeks after injection in the msVLDL group. LV dilatation developed significantly until 6 weeks. (msVLDL vs. control, $ p < 0.05; msVLDL vs. nVLDL, # p < 0.05; nVLDL vs. control, * p < 0.05); (D) No significant difference in body weight of the groups.